A case of recurrent acute febrileneutrophilicdermatosis in a patient with idiopathic cytopenia of undetermined significance. This is the first report of recurrent acute febrileneutrophilicdermatosis in a patient with idiopathic cytopenia of undetermined significance. The patient progressed to acute myeloid leukaemia 4 months after onset.
FebrileNeutrophilicDermatosis We value your privacyWe and our partners store and/or access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised ads and content, ad and content measurement, and audience insights, as well as to develop and improve products. With your permission we and our partners LE, et al; Sweet's syndrome in children. South Med J. 1994 FebHisanaga K, Iwasaki Y, Itoyama Y; Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology. 2005 May 24Su WP, Liu HN; Diagnostic criteria for Sweet's syndrome. Cutis. 1986 Marvon den Driesch P; Sweet's syndrome (acute febrileneutrophilicdermatosis) J Am Acad Dermatol. 1994 OctCohen PR, Kurzrock R; Sweet's
Azathioprine Hypersensitivity Syndrome: Two Cases of FebrileNeutrophilicDermatosis Induced by Azathioprine Azathioprine is an immunosuppressive agent used in the treatment of immune-mediated diseases. Azathioprine hypersensitivity syndrome is a rare adverse reaction occurring a few days to weeks after the administration of azathioprine. A 36-year-old male with ulcerative colitis presented
Acute febrileneutrophilicdermatosis associated with JAK-2 positive myeloproliferative disorder We present a case of a 77-year-old man with a history of myeloproliferative disorder. He was admitted with a 2-week history of erythaema, swelling and significant pain of the right forearm following a mechanical fall at home, which had caused a skin laceration. During his admission, he developed demonstrated a dense infiltrate of neutrophils and neutrophilic debris in keeping with acute febrileneutrophilicdermatosis (Sweet's syndrome). He was treated with oral steroids and after that he had a complete resolution of symptoms. However, he required a period of rehabilitation before returning home.
Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrileneutrophilicdermatosis in a woman with recurrent breast cancer Sweet's syndrome, also referred to as acute febrileneutrophilicdermatosis, can either occur as an idiopathic disorder or associated with another condition, including cancer, or induced by exposure to a drug. Proton pump inhibitors selectively inhibit gastric parietal cell H+-K+-adenosine triphosphatase and are most commonly used for the treatment of gastroesophageal reflux disease. Proton pump inhibitor-associated Sweet's syndrome is described in a woman with recurrent breast cancer. PubMed was used to search the following terms, separately and in combination: acute febrileneutrophilicdermatosis, breast cancer, malignancy, paraneoplastic, proton pump
Acute febrileneutrophilicdermatosis (Sweet's syndrome). To highlight the recent observations regarding not only research but also the clinical features and management of Sweet's syndrome. Some of the new insights concerning Sweet's syndrome include: (1) bortezomib-induced Sweet's syndrome (some of which are the histiocytoid variant), (2) a rare extracutaneous manifestation of Sweet's syndrome cardiac involvement in patients with post-Sweet's syndrome cutis laxa. Treatment advances include antitumour necrosis factor- alpha drugs; however, these medications have also been associated with inducing Sweet's syndrome. Nearly 50 years after the initial description of an acute febrileneutrophilicdermatosis by Dr Robert Douglas Sweet, the dermatosis remains a fascinating condition with regard
Acute FebrileNeutrophilicDermatosis Acute FebrileNeutrophilicDermatosis - Dermatologic Disorders - MSD Manual Professional Edition MSD Manual Please confirm that you are a health care professionalYes No Leave this Site? The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.Continue Cancel honeypot NeutrophilicDermatosis / * * * * * OTHER TOPICS IN THIS CHAPTER Introduction to Hypersensitivity and Reactive Skin Disorders Acute FebrileNeutrophilicDermatosis Drug Eruptions and Reactions Erythema Multiforme Erythema Nodosum Granuloma Annulare Panniculitis Pyoderma Gangrenosum Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Acute FebrileNeutrophilicDermatosis (Sweet
and pulmonary fibrosis); HaemoptysisPulmonary haemorrhage 8 MedDRA system organ class Adverse reactions Very common (≥1/10) Common (≥1/100 to <1/10) Uncommon (≥1/1,000 to <1/100) Rare (≥1/10,000 to <1/1,000) Gastrointestinal disorders Nausea1 Skin and subcutaneous tissue disorders Sweet’s syndrome (acute febrileneutrophilicdermatosis)1,2; Cutaneous vasculitis1,2Stevens-Johnson syndrome
including vital signs and lymph node assessment. 2. Rule out other potential etiologies including infection, other drug reaction, underlying systemic disease. Consider the possibility of a medical emergency including DRESS, acute febrileneutrophilicdermatosis (Sweet syndrome), SJS/TEN. 3. Complete biologic work-up including CBDd, liver enzymes/function, and renal function if indicated, complete
Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. BackgroundAcute febrileneutrophilicdermatosis (Sweet syndrome) is a potentially fatal multiorgan inflammatory disease characterized by fever, leukocytosis, and a rash with a neutrophilic infiltrate. The disease pathophysiology remains elusive, and current dogma suggests
A case of neonatal sweet syndrome associated with mevalonate kinase deficiency. Sweet syndrome (SS), also known as acute febrileneutrophilicdermatosis, is an immunologic syndrome characterized by widespread neutrophilic infiltration. Histiocytoid Sweet syndrome (H-SS) is a histopathologic variant of SS. While SS most commonly occurs in adults, this case report discusses an infant patient who
be a useful step in evaluation. For clindamycin, delayed maculopapular exanthems are the most common reactions. There are case reports of clindamycin associated with drug rash with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), acute febrileneutrophilicdermatosis, and symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). For linezolid